Insider trading

Period: 120 months Stock: AORT + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

267 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

267 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

267 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

267 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
267 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
267 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

267 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
13 Nov 2025
Horton Amy VP, Chief Accounting Officer
Sold at will
$159.68K 3,482 at 45.86
2.4%
Not planned
11 Nov 2025
Holloway Jean F SVP, General Counsel
Sold at will
$461.80K 10,000 at 46.18
5.6%
Not planned
10 Nov 2025
Mackin James P President & CEO
Sold at will
$784.40K 17,580 at 44.62
2.1%
Not planned
10 Nov 2025
Davis John E Chief Commercial Officer
Sold at will
$150.50K 3,373 at 44.62
1.6%
Not planned
10 Nov 2025
Holloway Jean F SVP, General Counsel
Sold at will
$132.07K 2,960 at 44.62
1.7%
Not planned
10 Nov 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will
$114.49K 2,566 at 44.62
4.0%
Not planned
10 Nov 2025
Horton Amy VP, Chief Accounting Officer
Sold at will
$79.82K 1,789 at 44.62
1.2%
Not planned
27 Aug 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will
$801.22K 18,200 at 44.02
22.1%
Not planned
25 Aug 2025
Holloway Jean F SVP, General Counsel
Sold at will
$443.70K 10,000 at 44.37
5.5%
Not planned
15 Aug 2025
Mackin James P President & CEO
Sold at will
$528.99K 12,500 at 42.32
1.4%
Not planned
12 Aug 2025
Holloway Jean F SVP, General Counsel
Sold at will 2×
$1.00M 23,356 at 43.01
11.9%
Not planned
12 Aug 2025
Davis John E Chief Commercial Officer
Sold at will
$471.76K 10,802 at 43.67
4.9%
Not planned
8 Aug 2025
Horton Amy VP, Chief Accounting Officer
Sold on a plan
$307.61K 7,992 at 38.49
5.2%
Planned (10b5-1)
17 Jun 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold on a plan 2×
$442.50K 15,000 at 29.50
18.9%
Planned (10b5-1)
13 Jun 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold on a plan 4×
$743.13K 26,132 at 28.44
24.8%
Planned (10b5-1)
27 May 2025
Holloway Jean F SVP, General Counsel
Sold at will
$253.69K 8,748 at 29.00
4.7%
Not planned
23 May 2025
Sold at will
$74.03K 2,600 at 28.47
7.3%
Not planned
21 May 2025
Holloway Jean F SVP, General Counsel
Sold at will
$287.85K 9,926 at 29.00
5.0%
Not planned
9 May 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will 2×
$307.27K 10,548 at 29.13
9.1%
Not planned
11 Mar 2025
Holloway Jean F SVP, General Counsel
Sold on a plan
$425.51K 18,020 at 23.61
8.4%
Planned (10b5-1)
11 Mar 2025
Davis John E Chief Commercial Officer
Sold on a plan
$356.55K 15,100 at 23.61
6.7%
Planned (10b5-1)
6 Mar 2025
Mackin James P President & CEO
Sold on a plan 2×
$2.19M 88,439 at 24.77
9.3%
Planned (10b5-1)
6 Mar 2025
Berry Lance A Executive VP, CFO
Sold at will
$121.76K 4,909 at 24.80
3.1%
Not planned
6 Mar 2025
Davis John E Chief Commercial Officer
Sold at will
$64.94K 2,618 at 24.80
1.2%
Not planned
6 Mar 2025
Holloway Jean F SVP, General Counsel
Sold at will
$52.69K 2,124 at 24.80
1.1%
Not planned
6 Mar 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will
$39.76K 1,603 at 24.80
1.4%
Not planned
6 Mar 2025
Horton Amy VP, Chief Accounting Officer
Sold at will
$26.00K 1,048 at 24.80
0.7%
Not planned
5 Mar 2025
Bought
$37.99K 1,500 at 25.33
4.4%
First buy in 3+ yrs
5 Mar 2025
SEMEDO ANTHONY B. Director · indirect
Bought
$15.15K 600 at 25.25
opened
First buy in 3+ yrs
5 Mar 2025
Holloway Jean F SVP, General Counsel
Sold at will
$11.93K 472 at 25.29
0.3%
Not planned
24 Feb 2025
Mackin James P President & CEO
Sold at will 4×
$1.15M 42,156 at 27.31
6.0%
Not planned
24 Feb 2025
Davis John E Chief Commercial Officer
Sold at will 4×
$176.31K 6,457 at 27.31
3.9%
Not planned
24 Feb 2025
Holloway Jean F SVP, General Counsel
Sold at will 4×
$145.68K 5,335 at 27.31
3.4%
Not planned
24 Feb 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will 4×
$127.98K 4,687 at 27.31
5.5%
Not planned
24 Feb 2025
Horton Amy VP, Chief Accounting Officer
Sold at will 4×
$90.74K 3,323 at 27.31
2.5%
Not planned
24 Feb 2025
Berry Lance A Executive VP, CFO
Sold at will
$88.99K 3,259 at 27.31
4.1%
Not planned
11 Dec 2024
Holloway Jean F SVP, General Counsel
Sold at will 2×
$243.11K 8,070 at 30.13
5.0%
Not planned
6 Dec 2024
Horton Amy VP, Chief Accounting Officer
Sold at will
$128.40K 4,329 at 29.66
3.1%
Not planned
4 Dec 2024
GREEN ANDREW M VP Regulatory
Sold on a plan
$228.54K 7,618 at 30.00
18.5%
Planned (10b5-1)
1 Oct 2024
Horton Amy VP, Chief Accounting Officer
Sold on a plan
$325.41K 12,430 at 26.18
8.2%
Planned (10b5-1)
26 Aug 2024
Holloway Jean F SVP, General Counsel
Sold at will
$84.10K 3,167 at 26.55
1.9%
Not planned
16 Aug 2024
Getz Matthew A VP, Human Resources
Sold at will 2×
$238.43K 9,420 at 25.31
21.6%
Not planned
15 Aug 2024
Holloway Jean F SVP, General Counsel
Sold at will
$61.39K 2,383 at 25.76
1.4%
Not planned
13 Aug 2024
Sold at will
$242.63K 9,709 at 24.99
22.1%
Not planned
10 May 2024
Holloway Jean F SVP, General Counsel
Sold at will
$29.28K 1,250 at 23.42
0.7%
Not planned
9 May 2024
Holloway Jean F SVP, General Counsel
Sold at will
$23.29K 979 at 23.79
0.6%
Not planned
20 Mar 2024
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will
$44.51K 2,183 at 20.39
2.6%
Not planned
15 Mar 2024
GREEN ANDREW M VP Regulatory
Sold on a plan
$29.24K 1,462 at 20.00
3.4%
Planned (10b5-1)
14 Mar 2024
GREEN ANDREW M VP Regulatory
Sold on a plan
$79.88K 3,994 at 20.00
8.6%
Planned (10b5-1)
12 Mar 2024
Getz Matthew A VP, Human Resources
Sold at will
$99.72K 5,000 at 19.94
10.3%
Not planned
Showing 51–100 of 267. ← Newer Page 2 of 6 Older →